Literature DB >> 1829849

The 'athletic heart syndrome'. A critical review.

K P George1, L A Wolfe, G W Burggraf.   

Abstract

Cardiological findings in athletes are often similar to those observed in clinical cases. Electrocardiographic and cardiac imaging abnormalities as well as physical findings may be the same in both of these groups. Bradycardia and rhythm disturbances are the most common abnormalities in athletes. Most athletes with abnormal electrocardiograms are asymptomatic and numerous investigators have failed to detect heart disease in association with such electrocardiograms. In contrast to cardiac dysfunction observed in clinical cases, enhanced or normal ventricular systolic and diastolic function have been reported in athletes. In endurance athletes, this is associated with very high values for maximal aerobic power (VO2max). Absolute and body size-normalised cardiac dimensions in most athletes do not approach values from chronic disease states, and may not exceed echocardiographic normal limits. In addition, pathological and physiological enlargement appear to be biochemically and functionally different. Myosin ATPase enzyme expression and calcium metabolism are different in rats with pathologically or physiologically induced enlargement. The reported biochemical differences underlie systolic and diastolic dysfunction in pathological enlargement. Conversely, trained rodents and humans have demonstrated enhanced systolic and diastolic function. It is important to note that cardiac enlargement observed in athletes is the result of normal adaptation to physical conditioning and/or hereditary influences. Conversely, pathological changes result from disease processes which can lead in turn to reduced function, morbidity and mortality. Since the mid 1970s echocardiography has been used to compare cardiac dimensions in male endurance- and resistance-trained athletes. A sport-specific profile of eccentric and concentric enlargement has been documented in endurance and resistance athletes, respectively. Subsequent studies of athletes have examined factors such as age, sex and degree of competitive success to determine their contribution to these sport-specific cardiac profiles. Unique athletic subgroups have also been analysed and have included ballet dancers, rowers, basketball players and triathletes. However, there is a paucity of data on cardiac dimensions in female athletes. Finally, physical conditioning studies have also examined echocardiographic dimensions before and after endurance and resistance training. Significant enlargement of internal dimensions, wall thickness or left ventricular mass have been reported but such increases are relatively small and by no means universal. Several conflicting explanations for enlarged cardiac dimensions appear in the literature. Chronic volume and pressure haemodynamic overloading during physical conditioning has been proposed to explain eccentric and concentric cardiac enlargement in endurance- and resistance-trained athletes respectively. However, twin studies suggest that hereditary factors may be important determinants of cardiac dimensions and/or the degree of cardiac adaptability to physical conditioning.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Year:  1991        PMID: 1829849     DOI: 10.2165/00007256-199111050-00003

Source DB:  PubMed          Journal:  Sports Med        ISSN: 0112-1642            Impact factor:   11.136


  189 in total

1.  Myofibrillar adenosine triphosphatase activity in congestive heart failure.

Authors:  N R ALPERT; M S GORDON
Journal:  Am J Physiol       Date:  1962-05

2.  Inheritance of heart structure and physical exercise capacity: a study of left ventricular structure and exercise capacity in 7-year-old twins.

Authors:  E Bielen; R Fagard; A Amery
Journal:  Eur Heart J       Date:  1990-01       Impact factor: 29.983

Review 3.  Endocrine responses to resistance exercise.

Authors:  W J Kraemer
Journal:  Med Sci Sports Exerc       Date:  1988-10       Impact factor: 5.411

4.  The heart: a target organ for estradiol.

Authors:  W E Stumpf; M Sar; G Aumüller
Journal:  Science       Date:  1977-04-15       Impact factor: 47.728

5.  The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats.

Authors:  T F Schaible; A Malhotra; G Ciambrone; J Scheuer
Journal:  Circ Res       Date:  1984-01       Impact factor: 17.367

6.  Left ventricular function in trained and untrained healthy subjects.

Authors:  B Z Bar-Shlomo; M N Druck; J E Morch; G Jablonsky; J D Hilton; D H Feiglin; P R McLaughlin
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

7.  Effect of habitual exercise on left ventricular response to exercise.

Authors:  J D Anholm; C Foster; J Carpenter; M L Pollock; C K Hellman; D H Schmidt
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1982-06

8.  Noninvasive evaluation of exercise training in college-age men.

Authors:  T D Adams; F G Yanowitz; A G Fisher; J D Ridges; K Lovell; T A Pryor
Journal:  Circulation       Date:  1981-11       Impact factor: 29.690

9.  Echocardiographic dimensions and maximal oxygen uptake in oarsmen during training.

Authors:  W Wieling; E A Borghols; A P Hollander; S A Danner; A J Dunning
Journal:  Br Heart J       Date:  1981-08

10.  Reproductive hormone increases in response to acute exercise in men.

Authors:  D C Cumming; L A Brunsting; G Strich; A L Ries; R W Rebar
Journal:  Med Sci Sports Exerc       Date:  1986-08       Impact factor: 5.411

View more
  24 in total

Review 1.  Sports-specific adaptations and differentiation of the athlete's heart.

Authors:  A Urhausen; W Kindermann
Journal:  Sports Med       Date:  1999-10       Impact factor: 11.136

Review 2.  Echocardiographic differentiation of pathological and physiological left ventricular hypertrophy.

Authors:  D J Hildick-Smith; L M Shapiro
Journal:  Heart       Date:  2001-06       Impact factor: 5.994

3.  Endurance rather than sprint running training increases left ventricular wall thickness in female athletes.

Authors:  Tomas Venckunas; Rasa Raugaliene; Birute Mazutaitiene; Sonata Ramoskeviciute
Journal:  Eur J Appl Physiol       Date:  2007-10-17       Impact factor: 3.078

Review 4.  Is there an optimal training intensity for enhancing the maximal oxygen uptake of distance runners?: empirical research findings, current opinions, physiological rationale and practical recommendations.

Authors:  Adrian W Midgley; Lars R McNaughton; Michael Wilkinson
Journal:  Sports Med       Date:  2006       Impact factor: 11.136

5.  The upper limit of physiological cardiac hypertrophy in elite male and female athletes in China.

Authors:  Biao Sun; Ji Zheng Ma; Yong Hong Yong; Yuan Yuan Lv
Journal:  Eur J Appl Physiol       Date:  2007-07-28       Impact factor: 3.078

6.  Echocardiographic parameters in athletes of different sports.

Authors:  Tomas Venckunas; Arimantas Lionikas; Jolanta E Marcinkeviciene; Rasa Raugaliene; Aleksandras Alekrinskis; Arvydas Stasiulis
Journal:  J Sports Sci Med       Date:  2008-03-01       Impact factor: 2.988

Review 7.  The athlete's heart: is big beautiful?

Authors:  R J Shephard
Journal:  Br J Sports Med       Date:  1996-03       Impact factor: 13.800

8.  The impact of chronic endurance and resistance training upon the right ventricular phenotype in male athletes.

Authors:  Victor Utomi; David Oxborough; Euan Ashley; Rachel Lord; Sarah Fletcher; Mike Stembridge; Rob Shave; Martin D Hoffman; Greg Whyte; John Somauroo; Sanjay Sharma; Keith George
Journal:  Eur J Appl Physiol       Date:  2015-03-17       Impact factor: 3.078

9.  Echocardiographic examination of cardiac structure and function in elite cross trained male and female Alpine skiers.

Authors:  K P George; P E Gates; G Whyte; R A Fenoglio; R Lea
Journal:  Br J Sports Med       Date:  1999-04       Impact factor: 13.800

10.  Relation between cardiac dimensions and peak oxygen uptake.

Authors:  K Steding; H Engblom; T Buhre; M Carlsson; H Mosén; B Wohlfart; H Arheden
Journal:  J Cardiovasc Magn Reson       Date:  2010-02-01       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.